A magnetic resonance imaging (MRI) contrast agent that can pass through the blood-brain barrier will allow doctors to detect deadly brain tumors called gliomas earlier, say Penn State College of Medicine researchers.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now